Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Eli Lilly's brand retatrutide is still investigational and not yet sold, but post-approval list pricing is projected at $1,1001,400/month
Superior Stability: In its freeze-dried state, the peptide is much less sensitive to temperature fluctuations during shipping and storage compared to premixed solutions
This peptide is increasingly studied for its role in longevity and as a promising tool in advanced metabolic and wellness therapies
Others sold under the same peptide label do almost nothing
US$ 23.45
US$ 26.91
US$ 29.88
US$ 22.02
US$ 27.11
